Published in J Infect Dis on June 01, 1972
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine (2007) 2.51
Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ (1993) 2.14
A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group. J Hyg (Lond) (1975) 1.67
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol (1994) 1.61
Humoral and cellular response in humans after immunization with influenza vaccine. Infect Immun (1973) 1.54
Immunological responsiveness of tuberculosis patients receiving rifampin. Antimicrob Agents Chemother (1974) 1.33
Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv Drug Deliv Rev (2012) 1.25
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clin Diagn Lab Immunol (1996) 1.22
Responses of volunteers to inactivated influenza virus vaccines. J Hyg (Lond) (1981) 1.12
Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. Vaccine (2011) 1.10
Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice. Infect Immun (1974) 1.10
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults. J Infect Dis (2012) 1.00
Purified viral neuraminidase vaccine to control influenza. Can Med Assoc J (1979) 0.87
Attenuated influenza A vaccine (Alice) in an adult population: vaccine-related illness, serum and nasal antibody production, and intrafamily transmission. J Clin Microbiol (1975) 0.87
Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine. J Hyg (Lond) (1985) 0.83
A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity. J Hyg (Lond) (1976) 0.81
The search for the ideal influenza vaccine. Postgrad Med J (1979) 0.81
Lymphocyte responses to hemagglutinin and neuraminidase subunits of influenza virus. J Clin Microbiol (1978) 0.80
Safety of intramuscular influenza vaccine in patients receiving oral anticoagulation therapy: a single blinded multi-centre randomized controlled clinical trial. BMC Blood Disord (2008) 0.79
Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. J Infect Dis (1973) 3.67
Pharmacology of gentamicin in man. J Infect Dis (1971) 3.16
Complications of smallpox vaccination, 1968. N Engl J Med (1969) 3.08
Clinical forms of gonococcal arthritis. N Engl J Med (1968) 2.58
Current therapeutics. 234. Gentamicin. Practitioner (1967) 2.54
Laboratory and clinical conditions for gentamicin inactivation by carbenicillin. Arch Intern Med (1972) 2.19
Antitoxin responses in the elderly to tetanus-diphtheria (TD) immunization. Am J Epidemiol (1978) 2.19
Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J Infect Dis (1990) 2.11
Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis (1970) 2.00
Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. J Infect Dis (1971) 1.97
Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin. J Infect Dis (1971) 1.89
An evaluation of the use of statistical methodology in the Journal of Infectious Diseases. J Infect Dis (1984) 1.82
Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones. Antimicrob Agents Chemother (1988) 1.70
Viremia in Asian influenza. Trans Assoc Am Physicians (1966) 1.70
Follow-up study: protective immunization in the elderly. Am J Public Health (1983) 1.66
Humoral and cellular response in humans after immunization with influenza vaccine. Infect Immun (1973) 1.54
Antibacterial activity of cinoxacin in vitro. Antimicrob Agents Chemother (1975) 1.50
Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA (1987) 1.49
Effect of isoprinosine against influenza and some other viruses causing respiratory diseases. Antimicrob Agents Chemother (1972) 1.48
Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob Agents Chemother (1979) 1.47
Acute respiratory illness among immunized and nonimmunized patients with high-risk factors during a split season of influenza A and B. J Infect Dis (1988) 1.46
Neutralizing activity in nasal secretions and serum in resistance of volunteers to parainfluenza virus type 2. J Immunol (1968) 1.42
First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob Agents Chemother (1991) 1.40
Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968. JAMA (1970) 1.35
Observations of the staphylococcal nasal carrier state. Ann N Y Acad Sci (1965) 1.34
Production of interferon in volunteers infected with Asian influenza. J Infect Dis (1970) 1.33
Immunological responsiveness of tuberculosis patients receiving rifampin. Antimicrob Agents Chemother (1974) 1.33
Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA (1975) 1.31
Prevention of influenza in the elderly. J Am Geriatr Soc (1982) 1.30
Netilmicin: clinical efficacy, tolerance, and toxicity. Antimicrob Agents Chemother (1978) 1.29
Prevention of illness from rhinovirus infection by a topical interferon inducer. N Engl J Med (1974) 1.27
High-pressure liquid chromatographic assay of netilmicin in plasma. Antimicrob Agents Chemother (1977) 1.21
Viruses causing common respiratory infection in man. IV. Reoviruses and Adenoviruses. J Infect Dis (1973) 1.17
Use and withdrawal of amantadine chemoprophylaxis during epidemic influenza A. Am Rev Respir Dis (1976) 1.15
Viremia with herpes simplex type 1 in adults. Four nonfatal cases, one with features of chicken pox. Ann Intern Med (1976) 1.15
Prospective study of prevalence, incidence, and source of herpesvirus infections in patients with renal allografts. J Infect Dis (1977) 1.14
Antiviral agents in influenza--summary of Influenza Workshop VIII. J Infect Dis (1976) 1.12
Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease. CMAJ (1987) 1.12
Attitudes and behavior of health care personnel regarding the use and efficacy of influenza vaccine. J Infect Dis (1985) 1.10
An unusual outbreak of brucellosis. Arch Intern Med (1975) 1.09
Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome. Am J Med (1986) 1.09
Viruses causing common respiratory infections in man. J Infect Dis (1973) 1.08
Epidemiology of accidental needle-puncture wounds in hospital workers. Am J Med Sci (1983) 1.08
Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med (1987) 1.06
In utero sensitization with influenza virus in man. Proc Soc Exp Biol Med (1975) 1.05
The limited effect of nasal interferon induced by rhinovirus and a topical chemical inducer on the course of infection. J Infect Dis (1973) 1.05
Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis (1986) 1.04
Influenza in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA (1974) 1.04
Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children. Bull World Health Organ (1973) 1.03
Prevention and control of influenza by chemoprophylaxis and chemotherapy. Prospects from examination of recent experience. JAMA (1976) 1.02
Methods for the clinical evaluation of antibiotics in urinary tract infections. Scand J Infect Dis Suppl (1978) 1.02
Efficacy of cinoxacin in urinary tract infections. Antimicrob Agents Chemother (1976) 1.01
Herpes virus latency in spinal ganglia of mice without illness. Proc Soc Exp Biol Med (1974) 1.00
Ocular vaccinia. An epidemiologic analysis of 348 cases. Arch Ophthalmol (1970) 1.00
Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine. Arch Virol (1975) 0.99
Protection with split and whole virus vaccines against influenza. Arch Intern Med (1973) 0.99
Biphasic, concentration-dependent and rate-limited, concentration-independent bacterial killing by an aminoglycoside antibiotic. J Infect Dis (1984) 0.98
Specific immunoglobulin-class antibody responses in the elderly before and after 14-valent pneumococcal vaccine. J Infect Dis (1985) 0.98
Analysis of a community hospital employee tuberculosis screening program 31 months after its inception. Am Rev Respir Dis (1977) 0.98
Pneumococcal bacteremia at a medical/surgical hospital for adults between 1975 and 1980. Am J Med (1984) 0.97
Topical enviroxime against rhinovirus infection. Antimicrob Agents Chemother (1982) 0.97
The Infectious Diseases Society of America and the elimination of tuberculosis. J Infect Dis (1990) 0.97
Fungal and mycobacterial infections in patients infected with the human immunodeficiency virus. J Antimicrob Chemother (1989) 0.97
Study of delayed hypersensitivity to myxoviruses induced by vaccines. Appl Microbiol (1969) 0.94
Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen. Am J Med (1984) 0.94
Prevention and control of influenza. Role of vaccine. Am J Med (1987) 0.94
Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir. JAMA (1985) 0.91
Respiratory failure secondary to Mycoplasma pneumoniae infection. South Med J (1979) 0.91
Human infection with Vibrio fetus. Antimicrob Agents Chemother (Bethesda) (1967) 0.91
Nasal-secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection. J Med Virol (1988) 0.91
Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis. J Infect Dis (1982) 0.91
Absence of imune deficiencies in a case of progressive multifocal leukoencephalopathy. Am J Med (1976) 0.91
Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro. J Med Virol (1992) 0.90
From the Infectious Diseases Society of America. Hospital epidemiology and infection control: the changing role of the specialist in infectious diseases. J Infect Dis (1981) 0.89
An outbreak of Streptococcus pyogenes infections in a nursing home. Ann Intern Med (1984) 0.89
Viruses causing common respiratory infections in man. V. influenza A (Asian). J Infect Dis (1975) 0.89
Search for latent cytomegalovirus in renal allografts. Infect Immun (1978) 0.89
Gentamicin plus carbenicillin. Lancet (1971) 0.89
Effectiveness of current killed influenza vaccines against influenza A-England-42-72. J Infect Dis (1973) 0.88
Experimental pseudomonas osteomyelitis: treatment with sisomicin and carbenicillin. J Bone Joint Surg Am (1974) 0.87
Cutaneous abscess caused by Legionella micdadei in an immunosuppressed patient. Ann Intern Med (1985) 0.87
Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression. Br J Ophthalmol (1988) 0.87
Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis. Am J Med (1988) 0.87
Influenza, influenza vaccine, and amantadine/rimantadine. J Fam Pract (1997) 0.87
Viruses causing common respiratory infections in man. 3. Respiratory syncytial viruses and coronaviruses. J Infect Dis (1973) 0.87
Epidemiologic studies of Reye's syndrome: cases seen in Pittsburgh, October 1973-April 1975. Am J Public Health (1976) 0.86
Reye syndrome with associated influenza A and B infection. JAMA (1975) 0.85
Factors associated with acquisition of Pseudomonas aeruginosa resistant to gentamicin. Am J Med Sci (1978) 0.84
Sensitivity of influenza A virus to amantadine. J Infect Dis (1977) 0.84
In vitro and clinical effects of cephaloridine: a semisynthetic antibiotic. Am J Med Sci (1967) 0.83
Clinical manifestations of infections with herpesviruses after kidney transplantation: a prospective study of various syndromes. Ann Surg (1978) 0.83
Perspective from a quarter century of antibiotic usage. JAMA (1974) 0.83
Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits. Antimicrob Agents Chemother (Bethesda) (1965) 0.83
Assay of aminoglycoside antibiotics in clinical specimens. J Infect Dis (1975) 0.83
Isolation of Mycoplasma pneumoniae from adults with respiratory infections. Arch Intern Med (1966) 0.82
Stress and sugar control in children with insulin-dependent diabetes mellitus. J Pediatr (1981) 0.82
Hepatitis B virus infection, hepatitis B vaccine, and hepatitis B immune globulin. J Fam Pract (1997) 0.82
Dual respiratory infection with parainfluenza and rhinovirus. The pathogenesis of transmitted infection in volunteers. Am Rev Respir Dis (1966) 0.81